Abstract:Background: Stent implantation represents the standard of care in coronary intervention. While a short stent implanted on a focal lesion located on the left anterior descending artery (LAD) seems a reasonable alternative to an internal mammary implant, the same for long stents is still debated. Methods: We reported the long-term data of 531 consecutive patients who underwent Percutaneous Coronary Intervention (PCI) with long stents in two highly specialized centres. The main inclusion criteria were the implantation of stents longer than 30 mm on the LAD and a minimum follow-up (FU) of five years. The primary endpoint was mortality, and the secondary endpoints were any myocardial infarction (MI), target vessel and lesion revascularization (TVR and TLR, respectively), and stent thrombosis (ST) observed as definite, probable, or possible. Results: In this selected population with characteristics of complex PCI (99.1%), the long-term follow-up (mean 92.18 ± 35.5 months) estimates of all-cause death, cardiovascular death, and any myocardial infarction were 18.3%, 10.5%, and 9.3%, respectively. Both all-cause and cardiovascular deaths are significantly associated with three-vessel disease (HR 6.8; confidence of interval (CI) 95% 3.844-11.934; p < 0.001, and HR 4.7; CI 95% 2.265-9.835; p < 0.001, respectively). Target lesion (TLR) and target vessel revascularization (TVR) are associated with the presence of three-lesion disease on the LAD (HR 3.4; CI 95% 1.984-5.781; p < 0.001; HR 3.9 CI 95% 2.323-6.442; p < 0.001, respectively). Re-PCI for any cause occurred in 31.5% of patients and shows an increased risk for three-lesion stenting (HR 4.3; CI 95% 2.873-6.376; p < 0.001) and the treatment of bifurcation with two stents (HR 1.6; 95% CI 1.051-2.414; p = 0.028). Stent thrombosis rate at the 5-year FU was 4.4% (1.3% definite; 0.9% probable; 2.1% possible), including a 1.7% rate of very-late thrombosis. The stent length superior to 40 mm was not associated with poor outcomes (all-cause death p = 0.349; cardiovascular death p = 0.855; MI p = 0.691; re-PCI p = 0.234; TLR p = 0.805; TVR p = 0.087; ST p = 0.189). Conclusion: At an FU of longer than five years, patients treated with stents longer than 30 mm in their LAD showed acceptable procedural results but poor outcomes.

[Diagnostic thoracotomy--a contribution to its value, indications and results].

Forgotten Biliary Plastic Stents: Complications, Management, and Clinical Outcomes

Altered regional clearance of 99Tcm-DTPA in radiation pneumonitis.

Additional endoscopic procedures instead of urgent surgery for retained common bile duct stones.

Clinical Efficacy of Suspended Overlength Biliary Stents Reformed from Nasobiliary Tubes for Prevention of Duodenobiliary Reflux( with Video)

Navigating the complexities of a forgotten double J stent

Reoperation of Biliary Tract by Laparoscopy: Experiences with 39 Cases.

[Phenacetin abuse I. Occurrence, per capita consumption and costs of treatment].

Cardiac papillary fibroelastoma: report of two cases.

Percutaneous placement of a retrievable fully covered metal stent with anchoring flaps for the treatment of biliary anastomotic stricture following LDLT

A review of problems following insertion of biliary stents illustrated by an unusual complication

Long Stent Implantation on the Left Anterior Descending Coronary Artery at a Follow-Up of More Than Five Years

[Long-term retrospective analysis of metallic stents in malignant biliary obstruction]

The time course of brain and blood catecholamines, catechol O-methyltransferase, and amino acids in rats convulsed by oxygen at high pressure.

Clinical Value of Endoscopic Biliary Stent Placement for Bile Leakage Following Hepatobiliary Surgery

Long-Term Outcomes Following Surgical Repair for Post-cholecystectomy Biliary Strictures

Mid-and Long-term Outcomes of Oddi Sphincter-preserved Cholangioplasty with Hepatico-subcutaneous Stoma(OSPCHS) for Hepatolithiasis:Report of 96 Cases

Long‐term Outcomes of Surgical Approaches for Bilateral Hepatolithiasis: A Real‐world Six‐decade Experience at a Single Center

Three-months duration of fully-covered metal stent for refractory dominant extra-hepatic biliary stricture among primary sclerosing cholangitis patients: efficacy and safety

Antegrade biliary stenting following surgical management of choledocholithiasis

Endoscopic stent insertion into the gallbladder for symptomatic gallbladder disease in patients with end-stage liver disease